SMITH TODD N 4
4 · Zyla Life Sciences · Filed Jan 2, 2020
Insider Transaction Report
Form 4
SMITH TODD N
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2020-01-02+180,000→ 180,000 totalExercise: $2.37Exp: 2030-01-02→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]Represents non-qualified stock option, 1/3 of which vests on the first anniversary of the grant date and 1/36 of which vests each month thereafter until the option is 100% vested.